Haloperidol Richter

Haloperidol Richter is a prescription medication that contains the active ingredient haloperidol. The product is supplied in an oral dosage form, with strength not specified in the available data. It belongs to the butyrophenone class of antipsychotics and is marketed in the European Union. Haloperidol works primarily as a dopamine D2 receptor antagonist and is used under medical supervision for several psychiatric conditions.

Haloperidol Richter is indicated for the management of several psychiatric disorders where dopamine blockade is therapeutic. It is commonly prescribed in clinical practice for the following conditions:

- Schizophrenia, including acute exacerbations - Acute psychotic episodes unrelated to schizophrenia - Manic episodes associated with bipolar disorder - Severe agitation that requires rapid control - Tourette syndrome when other treatments are insufficient

Side effects of haloperidol can vary in frequency and severity. Patients should be aware of both common and potentially serious reactions.

Common: - Drowsiness or sedation - Extrapyramidal symptoms such as tremor or rigidity - Dry mouth - Constipation - Blurred vision - Weight gain

Serious: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hypotension - Cardiac arrhythmias (QT prolongation) - Elevated prolactin levels causing galactorrhea or menstrual disturbances

Before starting Haloperidol Richter, certain precautions should be considered to ensure safe use:

- Assess cardiovascular status, especially in patients with a history of arrhythmias or heart disease. - Monitor for signs of extrapyramidal symptoms and tardive dyskinesia during prolonged therapy. - Evaluate liver and kidney function, as impairment may affect drug clearance. - Use cautiously in patients with a history of seizures or epilepsy. - Discuss pregnancy and breastfeeding plans with a healthcare provider, as safety data are limited. - Review any history of neuroleptic malignant syndrome before initiating treatment.

Haloperidol can interact with several other medications, influencing its efficacy and safety profile.

Avoid: - Other dopamine antagonists or antipsychotics, which may increase the risk of extrapyramidal symptoms. - Medications that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics). - Strong CYP3A4 inhibitors such as ketoconazole, which can raise haloperidol plasma levels.

Use with caution: - CNS depressants (e.g., benzodiazepines, opioids) that may enhance sedation. - Anticholinergic agents, which can mask early signs of extrapyramidal side effects. - CYP2D6 substrates, as haloperidol may affect their metabolism. - Alcohol, which can increase central nervous system depression.